Long-Term Survival and Failure Outcomes of Single-Fraction Stereotactic Body Radiation Therapy in Early Stage NSCLC
Introduction: This study aims to report our 13-year institutional experience with single-fraction stereotactic body radiation therapy (SF-SBRT) for early stage NSCLC. Methods: A single-institutional retrospective review of patients with biopsy-proven peripheral cT1-2N0M0 NSCLC undergoing definitive...
Main Authors: | Austin J. Iovoli, MD, Sharan Prasad, BSc, Sung Jun Ma, MD, Fatemeh Fekrmandi, MD, MSc, Nadia K. Malik, MD, Simon Fung-Kee-Fung, MD, Mark K. Farrugia, MD, PhD, Anurag K. Singh, MD |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-12-01
|
Series: | JTO Clinical and Research Reports |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2666364323001418 |
Similar Items
-
Comparison of Survival Outcomes of Single- and Five-Fraction Schedules of Stereotactic Body Radiation Therapy for Early-Stage Central or Peripheral NSCLC
by: Karen Huang, et al.
Published: (2023-03-01) -
Quality of Life After Stereotactic Body Radiation Therapy or Surgery for Early-Stage NSCLC: A Systematic ReviewKey Points
by: Austin J. Iovoli, MD, et al.
Published: (2022-11-01) -
Differences between Survival Rates and Patterns of Failure of Patients with Lung Adenocarcinoma and Squamous Cell Carcinoma Who Received Single-Fraction Stereotactic Body Radiotherapy
by: Tyler V. Schrand, et al.
Published: (2024-02-01) -
Adrenal oligometastasis cured with stereotactic ablative radiotherapy
by: Julia Malone, BSC, et al.
Published: (2020-11-01) -
Radiosurgery and fractionated stereotactic body radiotherapy for patients with lung oligometastases
by: Goda G. Kalinauskaite, et al.
Published: (2020-05-01)